A Study to Test Different Doses of BI 891065 Alone and in Combination With BI 754091 in Asian Patients With Different Types of Advanced Cancer (Solid Tumours)
Clinical trial NCT04138823 · COMPLETED
Trial details
- NCT number
- NCT04138823
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-26
- Primary completion
- 2023-05-17
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.